Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

413
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
413
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Airway immune signatures of protection and disease progression in recent human tuberculosis household contacts.

Nature immunology·2026
Same author

The role of FMR1 mRNA structure on the efficiency of non-canonical translation of toxic polyglycine protein.

Nucleic acids research·2026
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026
Same author

Jugular implantation of a leadless ventricular pacemaker ten days after transfemoral leadless atrial pacemaker placement.

Kardiologia polska·2026
Same author

The Preliminary Study for the Trial of Using Selected miRNAs for the Laboratory Diagnosis of Colorectal Cancer.

International journal of molecular sciences·2026
Same author

Association Analyses Between the <i>NPPB</i>:rs198389 Gene Polymorphism, NT-proBNP Serum Concentrations and Phenotypic Features in Patients with Heart Failure.

Genes·2026

Related Experiment Video

Updated: Jan 4, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.6K

Aspirin and its pleiotropic application.

Jolanta Hybiak1, Izabela Broniarek2, Gerard Kiryczyński1

  • 1Department of Pathology, Pomeranian Medical University, Szczecin, Poland.

European Journal of Pharmacology
|November 1, 2019
PubMed
Summary
This summary is machine-generated.

Aspirin, a versatile anti-inflammatory drug, demonstrates diverse applications beyond its original use, including anticoagulant and cancer risk reduction. Its benefits and risks require careful consideration for novel therapeutic uses.

Keywords:
AnticoagulantAspirinCancerCardiovascularCyclooxygenasePre-eclampsia

More Related Videos

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

887
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.3K

Related Experiment Videos

Last Updated: Jan 4, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.6K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

887
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.3K

Area of Science:

  • Pharmacology
  • Drug Discovery
  • Medical Chemistry

Background:

  • Aspirin (acetylsalicylic acid) is a foundational synthetic drug with established anti-inflammatory properties.
  • It functions as an irreversible inhibitor of cyclooxygenase (COX) enzymes, impacting prostaglandin and thromboxane synthesis.
  • Beyond inflammation, aspirin exhibits pleiotropic effects, leading to diverse therapeutic explorations.

Purpose of the Study:

  • To summarize the multifaceted applications of aspirin.
  • To highlight aspirin's expanded roles beyond its anti-inflammatory origins.
  • To underscore the importance of evaluating risks and benefits for new aspirin applications.

Main Methods:

  • Review of existing literature on aspirin's pharmacological actions.
  • Analysis of clinical studies investigating aspirin's efficacy in various conditions.
  • Synthesis of data regarding aspirin's pleiotropic effects and molecular mechanisms.

Main Results:

  • Aspirin's applications extend to anticoagulant therapy, cardiovascular disease prevention (myocardial infarct), and pre-eclampsia prophylaxis.
  • Evidence suggests aspirin intake may reduce colorectal cancer risk due to its anti-inflammatory properties.
  • Emerging research explores aspirin for neurologic conditions like Alzheimer's disease.

Conclusions:

  • Aspirin possesses a wide range of therapeutic applications, including novel uses in cardiovascular, obstetric, oncologic, and neurologic fields.
  • Careful consideration of both benefits and risks, potentially guided by molecular markers, is crucial for optimizing aspirin's use.
  • The pleiotropic nature of aspirin warrants continued investigation for innovative treatment strategies.